Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine (Q40640928)

22 September 2017

title

Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine (English)

1 reference

22 September 2017

1 reference

Hans J Netter

1

1 reference

22 September 2017

Wai-Ping Woo

2

1 reference

22 September 2017

Robert Tindle

3

1 reference

22 September 2017

Roderick I Macfarlan

4

1 reference

22 September 2017

Eric J Gowans

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

21

1 reference

22 September 2017

issue

21-22

1 reference

22 September 2017

page(s)

2692-2697

1 reference

Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Virus-like particles induce MHC class I-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

A topological model for hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Insertions in the hepatitis B surface antigen. Effect on assembly and secretion of 22-nm particles from mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Immunogenicity of hepatitis B vaccine in guinea-pigs, mice and man.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Immune response to hepatitis B virus proteins: relevance of the murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

A new technique for the assay of infectivity of human adenovirus 5 DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Use of Prior Vaccinations for the Development of New Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

The B cell targeted adjuvant, CTA1-DD, exhibits potent mucosal immunoenhancing activity despite pre-existing anti-toxin immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

Prior immunity to a carrier enhances antibody responses to hCG in recipients of an hCG-carrier conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2803%2900182-8

7 January 2021

10.1016/S0264-410X(03)00182-8

Identifiers

DOI

1 reference

22 September 2017

1 reference